Publication: Prognostic factors of patients who received chemotherapy after cranial irradiation for non-small cell lung cancer with brain metastases: A retrospective analysis of multicenter study (Anatolian Society of Medical Oncology)
Loading...
Program
relationships.isAuthorOf
Author
Inal, Ali
Kodaz, Hilmi
Odabas, Hatice
Duran, Ayse Ocak
Seker, Mehmet Metin
Inanc, Mevlide
ELKIRAN, EMİN TAMER
Gunaydin, Yusuf
Menekse, Serkan
Topcu, Turkan Ozturk
Advisor
Language
Type
Publisher
Journal Title
Journal ISSN
Volume Title
Abstract
Purpose: Almost half of all patients diagnosed with non-small cell lung cancer (NSCLC) have distant metastases at presentation. One-third of patients with NSCLC will have brain metastases. Without effective treatment, the median survival is only 1 month. However, it is difficult to treat brain metastases with systemic chemotherapy since the agents have difficulty crossing the blood-brain barrier. Therefore, it is important to estimate the patient-s survival prognosis. The aim of this study was to analyze prognostic factors for survival in Turkish patients who received chemotherapy after cranial irradiation for NSCLC with brain metastases.
Description
Source
Keywords
Keywords
Citation
Inal A., Kodaz H., Odabas H., Duran A. O. , Seker M. M. , Inanc M., ELKIRAN E. T. , Gunaydin Y., Menekse S., Topcu T. O. , et al., -Prognostic factors of patients who received chemotherapy after cranial irradiation for non-small cell lung cancer with brain metastases: A retrospective analysis of multicenter study (Anatolian Society of Medical Oncology)-, JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, cilt.14, ss.578-582, 2018